Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019

Published:2021-03-01 Issue:Suppl 1 Volume:36 Page:S253-S263
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Kim Ji-Won,Kim Eun Jin,Kwon Hyun Hee,Jung Chi Young,Kim Kyung Chan,Choe Jung-Yoon,Hong Hyo-Lim

Funder

Research Institute of Medical Science, Catholic University of Daegu

Daegu Medical Association COVID-19 scientific committee

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2020-224.pdf

Reference29 articles.

1. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

2. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

3. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

4. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV and COVID-19 Disease;Seminars in Respiratory and Critical Care Medicine;2023-01-16

2. The trading of space for time under weakly activated catalysis: expeditious synthesis of β-NH₂ alcohols via a direct ammonolysis of epoxides with ammonia;Green Chemistry;2023

3. Lopinavir-ritonavir for SARS-CoV-2 infection: a systematic review;Pneumologia;2022-10-01

4. Hydroxychloroquine/chloroquine and the risk of acute kidney injury in COVID-19 patients: a systematic review and meta-analysis;Renal Failure;2022-03-07

5. Efficacy of lopinavir–ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis;Future Virology;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3